A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
Completed · Phase 2
Conditions studied: Hypogonadism
In brief
The purpose of this study is to determine whether one or more fispemifene dose regimens are more effective than placebo in the treatment of hypogonadism in older men.
Key facts
- Study ID
- NCT00290134
- Run by
- QuatRx Pharmaceuticals Company
- People needed
- 100
- Starts
- 2006-02-01
- Expected to finish
- 2007-10-01
- Last updated by the study team
- 2008-03-03
Who can join
Age: 40 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Total testosterone level <240 ng/dL
- Serum LH and FSH levels within normal limits
You may not qualify if…
- Elevated prolactin
- Evidence of Benign Prostatic Hypertrophy
- History of or current breast cancer, prostate cancer, abnormal DRE or elevated PSA or any other malignancy
- Clinically significant endocrine/metabolic or cardiovascular disease
- Significant polycythemia
Where it is running
- Clinical Research Site — Huntsville, Alabama, United States
- Clinical Research Site — Modesto, California, United States
- Clinical Research Site — Aurora, Colorado, United States
- Clinical Research Site — Waterbury, Connecticut, United States
- Clinical Research Site — New Port Richey, Florida, United States
- Clinical Research Site — Tallahassee, Florida, United States
- Clinical Research Site — Peoria, Illinois, United States
- Clinical Research Site — Greenbelt, Maryland, United States
- Clinical Research Site — Las Vegas, Nevada, United States
- Clinical Research Site — Garden City, New York, United States
- Clinical Research Site — Poughkeepsie, New York, United States
- Clinical Research Site — Williamsville, New York, United States
- Clinical Research Site — Bethany, Oklahoma, United States
- Clinical Research Site — Greer, South Carolina, United States
- Clinical Research Site — San Antonio, Texas, United States
- Clinical Research Site — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.